Buy rating on Cytori
March 16, 2015 at 16:43 PM EDT
Bezinga
noted that Maxim has a Buy rating on Cytori Therapeutics Inc. (Nasdaq:
CYTX) with a $7 price target. The stock price gained 17 cents to close
at $1.37.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.